Reduced insulin sensitivity with continuous hepatic production and a release of glucose in the fed state is thought to result in long-term hyperglycemia and hyperinsulinemia and to impair muscle insulin sensitivity, and thereby promoting the development of type 2 diabetes mellitus. The gene discussed is INS; the disease is Hyperinsulinemia.